Tsi Health Sciences (Europe) Limited
Registered name: TSI HEALTH SCIENCES (EUROPE) LIMITED
Tsi Health Sciences (Europe) Limited made £20.7m revenue and £12k profit in the year to 31 Dec 2024. read from filing text
Tsi Health Sciences (Europe) Limited’s revenue grew 11% to £20.7m in the year to 31 Dec 2024, with £12k profit and 8 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Bury; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Bury, North West
- Age
- 21 yrs · since 2005
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “TSI Group Limited is the ultimate parent company, and is the smallest and largest group for which consolidated accounts including TSI Health Sciences (Europe) Limited are prepared. The registered offi”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 |
|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | |||
| Revenue (turnover) | £24.1m | £18.6m | £20.7m |
| Cost of sales | £21.9m | £17.1m | £20m |
| Gross profit | £2.1m | £1.5m | £755k |
| Operating profit | £439k | −£8.7k | £14.9k |
| Profit before tax | £439k | −£10.1k | £14.9k |
| Profit after tax | £354k | −£11.4k | £12k |
| Profit (best available) | £354k | −£11.4k | £12k |
| Staff costs | £459k | £535k | £523k |
| Employees (average) | 8 | 8 | 8 |
| Ratios | |||
| Profit margin | 1.5% | −0.1% | 0.1% |
| Gross margin | 8.8% | 7.8% | 3.6% |
| Revenue per employee | £3m | £2.3m | £2.6m |
| Profit per employee | £44.3k | −£1.4k | £1.5k |
| Cash conversion | 17.3% | — | −3529% |
| Growth (year on year) | |||
| Revenue growth | — | ▼22.7% | ▲11.5% |
| Profit growth | — | ▼103.2% | — |
| Headcount growth | — | 0% | 0% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £2.2m | £2m | £2.6m |
| Net assets | £578k | £567k | £579k |
| Fixed assets | £6.7k | £3.8k | £7.7k |
| Current assets | £8.9m | £9.7m | £11.2m |
| Debtors | £3.8m | £4.3m | £4.5m |
| Deferred income | £349k | £185k | £44.2k |
| Cash from operations | £76.1k | £60.8k | −£525k |
| Source | FullAccounts · bulk data Jul 2024 | FullAccounts · bulk data Jul 2024 | FullAccounts · bulk data Apr 2025 |
How the business works
- Profit margin
- 0.1%
- Profit ÷ revenue.
- Gross margin
- 3.6%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £2.6m
- Revenue ÷ average employees.
- Profit per employee
- £1.5k
- Profit ÷ average employees.
- Cash conversion
- −3529%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0.2%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 21.7%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲2%
- Now £579k
- Cash at bank
- ▲25%
- Now £2.6m
- Headcount
- 0%
- Now 8
- Deferred income
- ▼76%
- Now £44.2k
- Fixed assets
- ▲106%
- Now £7.7k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Serb LtdWeybridge · Wholesale of pharmaceutical goods
- Revenue
- £20.9m
- Profit
- £2.8m
- Staff
- —
- Paul Hartmann LimitedPilsworth Road · Wholesale of pharmaceutical goods
- Revenue
- £21.4m
- Profit
- £277k
- Staff
- 81
- Richardson Healthcare LimitedWholesale of pharmaceutical goods
- Revenue
- £19.2m
- Profit
- £2.2m
- Staff
- 16
- Trion Pharma LimitedCoventry · Wholesale of pharmaceutical goods
- Revenue
- £19.2m
- Profit
- £6.2m
- Staff
- 18
- Ibsa Pharma LimitedWatford · Wholesale of pharmaceutical goods
- Revenue
- £22.5m
- Profit
- £412k
- Staff
- 49
- Agrihealth (N.i.) LimitedLurgan · Wholesale of pharmaceutical goods
- Revenue
- £22.7m
- Profit
- £1.1m
- Staff
- 60
Sources
Latest figures from FullAccounts for the year to 31 Dec 2024 (profit £12k), from the Companies House accounts bulk data published Apr 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.